Navigation Links
Study reveals classic symbiotic relationship between ants, bacteria

Ants that tend and harvest gardens of fungus have a secret weapon against the parasites that invade their crops: antibiotic-producing bacteria that the insects harbor on their bodies.

Writing today in the journal Science, an international team led by University of Wisconsin-Madison bacteriologist Cameron Currie illustrates the intricate and ancient nature of this mutualistic relationship. The researchers found that the ants house the bacteria in specialized, highly adapted cavities and nourish them with glandular secretions-an indication that the ants, bacteria, fungus and parasites have likely been evolving together for tens of millions of years.

"Every ant species [that we have examined] has different, highly modified structures to support different types of bacteria," says Currie. "This indicates the ants have rapidly adapted to maintain the bacteria. It also indicates that the co-evolution between the bacteria and the ants, as well as the fungus and parasites, has been occurring since very early on, apparently for tens of millions of years."

Furthermore, Currie adds, the fact that the species have coexisted for so long means there might be a mechanism in place to decrease the rate of antibiotic resistance - which could help address a significant problem facing modern medicine. "We can learn a lot about our own use of antibiotics from this system," he says.

Currie studies the intricate relationships between certain species of ants in central and South America, the fungus they cultivate for food, the parasite that invades the fungus, and the bacteria that the ants harbor to fight the parasite. The phenomenon is a classic example of mutually beneficial symbiosis, and Currie views it as a model system with the potential to shed light on the way other organisms interact.

Although the ants and their fungus gardens had been closely studied for dozens of years, Currie was the first scientist to identify the crucial role of bac teria and the antibiotics they produce. He made a key insight that white spots on the ants, which were previously dismissed as "waxy blooms," were actually colonies of bacteria.

In the latest phase of his research, Currie, who began this study when he was at the University of Kansas, and his team removed the external blooms of bacteria from two ant species in the genus Cyphomyrmex and examined the exoskeleton beneath with a high-powered microscope. Their investigation revealed crypts attached to endocrine glands, both of which were previously unnoticed by scientists.

In fact, the crypts are specially adapted to the type of bacteria each species harbors - evidence that the ants are capable of rapidly changing to maintain their bacterial residents.

"These two species of ants are very difficult to differentiate other than through molecular analysis," says Currie. "There are almost no morphological, or physical, differences between the two. However, the crypts in the exoskeleton are distinguishable. We can actually use them to tell the two species apart."

The degree of specialization indicates that the association between the ants and the bacteria is ancient, says Currie, and likely vital to the species' survival. The phenomenon extends beyond the two species of Cyphomyrmex to about 210 species of fungus-growing ants, which harbor many different species of a specific group of bacteria.

"For me, it shows us how little we know about natural systems and microbes in nature. Fungus-growing ants are very well studied, yet this morphological characteristic went unnoticed until now. What other organisms might be taking advantage of this type of association? What don't we know about other systems that are not as closely studied as these ants?"

Currie's collaborators include Michael Poulsen and Jacobus Boomsma of the University of Copenhagen, John Mendenhall of the University of Texas at Austin, and Johan Billen of the Cath olic University of Leuven in Belgium. Currie, who began this work while at the University of Kansas, is also affiliated with the Smithsonian Tropical Research Institute in Panama.


Source:University of Wisconsin-Madison

Related biology news :

1. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
2. Emory Study Tests Bone Marrow Stem Cells to Improve Circulation in Legs
3. UCLA Study Shows One-Third of Drug Ads in Medical Journals Do Not Contain References Supporting Medical Claims
4. Study Demonstrates Gene Expression Microarrays are Comparable and Reproducible
5. Study Links Ebola Outbreaks To Animal Carcasses
6. Breakthrough Microarray-based Technology for the Study of Cancer
7. NYU Study Reveals How Brains Immune System Fights Viral Encephalitis
8. Study finds more than one-third of human genome regulated by RNA
9. Leukemia Drug Breakthrough Study In New England Journal Of Medicine
10. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
11. New Study from Affymetrix Laboratories Points to Changing View of How Genome Works
Post Your Comments:

(Date:10/12/2015)... 9, 2015 Research and Markets ( ... new report "Biometrics: Market Shares, Strategies, and Forecasts, ... --> --> The study is ... market segment. Research represents a selection from the mountains ... market materials, with selections made by the most senior ...
(Date:10/8/2015)... Calif. , Oct. 8, 2015 ... of human interface solutions, announced today that it ... of fiscal 2016 on Thursday, October 22, 2015, ... host a corresponding conference call for analysts and ... during which management may discuss forward-looking information.    ...
(Date:10/6/2015)... , Oct. 6, 2015 Track Group, Inc. ... that it has signed a contract with the Virginia ... the full range of sentences under the Department,s oversight. ... the Americas. "This contract with the Virginia DOC will ... US and advances our position as a trusted leader ...
Breaking Biology News(10 mins):
(Date:10/13/2015)... SPRINGS, Florida , October 13, 2015 ... AVXLD), Juno Therapeutics, Inc. (NASDAQ: JUNO ), and ... ARRY ), Avanex Life Sciences Corp. (OTCQX: AVXLD), ... Pharmaceuticals, Inc. (NASDAQ: PGNX ) --> ... and the biotech industry can potentially lead to advancements ...
(Date:10/13/2015)... 13, 2015  According to Kalorama Information, the ... $102 billion by the end of 2015. Clinical ... industry, as it is estimated that approximately 80% ... tests. In addition to diagnosing patients, clinical lab ... progression, monitor drug treatment and conditions, and determine ...
(Date:10/13/2015)... ... ... Proove Biosciences, a commercial and research leader ... Medicine of the University of Southern California (USC) Pain Center to study ... Clinical Objectives Linking Genotypic and Phenotypic Association with Pain Outcomes) is one of ...
(Date:10/12/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ), ... and patent-protected processes to develop and market advanced products ... Sports Medicine, Ophthalmic, and the Dental sectors of healthcare, ... filed against the Company has been dismissed by the ... and CEO, stated, "As we suspected, this case was ...
Breaking Biology Technology: